Last update Aug. 18, 2020

Antazoline

Very Low Risk

Safe. Compatible. Minimal risk for breastfeeding and infant.

Antihistaminic drug for topical use on the eye.

Since the last update we have not found any published data on its excretion in breast milk.

Like most ophthalmologic compounds for topical use a low dose and poor absorption make it compatible with breastfeeding.
Systemic absorption can be minimized by pressing on the tear duct (inner canthus of the eye) with a finger for 1-2 minutes (Bausch 2018).


See below the information of this related product:

  • Naphazoline (Moderately safe. Probably compatible. Mild risk possible. Follow up recommended. Read the Comment.)

Alternatives

We do not have alternatives for Antazoline since it is relatively safe.

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

Antazoline is also known as


Antazoline in other languages or writings:

Group

Antazoline belongs to this group or family:

Tradenames

Main tradenames from several countries containing Antazoline in its composition:

References

  1. Bausch. Tropicamide. Drug Summary. 2018 Full text (in our servers)
  2. AEMPS. Antazolina-Nafazolina. Ficha técnica. 2016 Full text (in our servers)

Total visits

4,375

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by IHAN of Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM